UID:
almahu_9948025897202882
Format:
1 online resource (795 p.)
ISBN:
1-281-05318-X
,
9786611053185
,
0-08-048835-8
Content:
Chronic obstructive pulmonary disease (COPD), which encompasses both chronic bronchitis and emphysema, is one of the most common respiratory conditions of adults in the developed world. Asthma and COPD: Basic Mechanisms and Clinical Management provides a unique, authoritative comparison of asthma and COPD. Written and edited by the world's leading experts, it is a comprehensive review of the most recent understanding of the basic mechanisms of both conditions, specifically comparing their etiology, pathogenesis, and treatments.* Highlights distinguishing features between asthma
Note:
Description based upon print version of record.
,
Front Cover; Asthma and COPD; Copyright Page; Contents; Foreword; Contributors; Preface; Dedication; Part I: Definitions, Epidemiology, and Genetics of Asthma and COPD; Chapter 1. Definitions; Chapter 2. Epidemiology; Chapter 3. Natural History; Chapter 4. Genetics; Part II: Physiology and Pathology of Asthma and COPD; Chapter 5. Pulmonary Physiology; Chapter 6. Airway Pathology; Chapter 7. Airway Remodeling; Chapter 8. Animal Models; Part III: Inflammatory Cells and Extracellular Matrix; Chapter 9. Mast Cells and Basophils; Chapter 10. Macrophages; Chapter 11. Eosinophils
,
Chapter 12. LymphocytesChapter 13. Neutrophils; Chapter 14. Fibroblasts; Chapter 15. Epithelial Cells; Chapter 16. Mucus and Mucin-Secreting Cells; Chapter 17. Airway Smooth Muscle; Chapter 18. Tracheobronchial Circulation; Chapter 19. Pulmonary Vessels; Chapter 20. Plasma Exudation; Chapter 21. Cell Adhesion Molecules; Chapter 22. Extracellular Matrix; Part IV: Inflammatory Mediators and Pathways; Chapter 23. Prostanoids; Chapter 24. Leukotrienes; Chapter 25. Kinins; Chapter 26. Reactive Oxygen Species; Chapter 27. Chemokines; Chapter 28. Cytokines; Chapter 29. Matrix Degrading Proteinases
,
Chapter 30. Growth FactorsChapter 31. Other Mediators of Airway Disease; Chapter 32. Nitric Oxide; Chapter 33. Transcription Factors; Chapter 34. Neural and Humoral Control; Part V: Pathogenic Mechanisms in Asthma and COPD; Chapter 35. Pathophysiology of Asthma; Chapter 36. Pathogenesis of COPD; Part VI: Triggers of Asthma and COPD; Chapter 37. Allergens; Chapter 38. Occupational Agents; Chapter 39. Infections; Chapter 40. Exercise as a Trigger; Chapter 41. Atmospheric Pollutants; Chapter 42. Drugs; Part VII: Clinical Assessment of Asthma and COPD; Chapter 43. Diagnosis
,
Chapter 44. Non-invasive Assessment of Airway InflammationChapter 45. Imaging; Chapter 46. Assessment of Disability; Part VIII: Therapies for Asthma and COPD; Chapter 47. Allergen Avoidance; Chapter 48. Smoking Cessation; Chapter 49. ß2-adrenoceptor Agonists; Chapter 50. Anticholinergic Bronchodilators; Chapter 51. Theophylline; Chapter 52. Corticosteroids; Chapter 53. Mediator Antagonists; Chapter 54. Antibiotics; Chapter 55. Long-term Oxygen Therapy; Chapter 56. Immunomodulators; Chapter 57. Pulmonary Vasodilators; Chapter 58. Ventilator Support; Chapter 59. Pulmonary Rehabilitation
,
Chapter 60. SurgeryChapter 61. Other Therapies; Chapter 62. Future Therapies; Chapter 63. Health Economics; Part IX: Clinical Management of Asthma and COPD; Chapter 64. Management of Chronic Asthma in Adults; Chapter 65. Acute Exacerbations of Asthma; Chapter 66. Childhood Asthma; Chapter 67. Treatment for Stable COPD; Chapter 68.Acute Exacerbations of COPD; Chapter 69. Education and Self-Management; Index
,
English
Additional Edition:
ISBN 0-12-079028-9
Language:
English
Bookmarklink